Ray Dalio’s Arrowhead Research ARWR Stock Holding History

Ray Dalio’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-95,552	Closed	-$5.99M	–	1018
2026 Q1	$5.99M	Buy	95,552 +35,586	+59%	+$2.25M	0.03%	378
2025 Q4	$3.98M	Buy	+59,966	New	+$2.94M	0.01%	600

Other funds holding ARWR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Ray Dalio's ARWR Position: Q2 2026 in Review

Ray Dalio sold out of Arrowhead Research (ARWR) in Q2 2026, closing a stake of 95,552 shares — an estimated $5.99M sold.

Ray Dalio first reported a position in ARWR in Q4 2025 and held it in 2 quarters. The position peaked at $5.99M in Q1 2026. 502 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

Ray Dalio reported no remaining Arrowhead Research position as of Q2 2026 after selling out during the quarter.
Ray Dalio sold 95,552 Arrowhead Research shares in Q2 2026, an estimated $5.99M.
Ray Dalio first reported a position in Arrowhead Research in Q4 2025 and held it in 2 quarters.
Ray Dalio's Arrowhead Research position peaked at $5.99M in Q1 2026.
502 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.